Gainers

  • Novo Integrated Sciences NVOS stock moved upwards by 25.6% to $0.32 during Friday's pre-market session. The company's market cap stands at $54.5 million.
  • Werewolf Therapeutics HOWL shares rose 20.0% to $2.58. The company's market cap stands at $91.9 million.
  • Pasithea Therapeutics KTTA stock rose 16.93% to $0.37. The market value of their outstanding shares is at $7.7 million.
  • Altamira Therapeutics CYTO shares moved upwards by 14.98% to $0.19. The company's market cap stands at $1.4 million.
  • Arcutis Biotherapeutics ARQT shares moved upwards by 13.96% to $2.53. The market value of their outstanding shares is at $238.2 million. As per the press release, Q3 earnings came out today.
  • CVRx CVRX stock moved upwards by 13.8% to $15.5. The market value of their outstanding shares is at $322.6 million.

Losers

  • Panbela Therapeutics PBLA stock fell 30.5% to $0.66 during Friday's pre-market session. The market value of their outstanding shares is at $1.9 million.
  • NexImmune NEXI shares decreased by 28.75% to $2.65. The market value of their outstanding shares is at $2.8 million.
  • Agilon Health AGL shares fell 14.04% to $14.52. The company's market cap stands at $5.8 billion. As per the news, the Q3 earnings report came out yesterday.
  • Erasca ERAS shares declined by 12.06% to $2.07. The company's market cap stands at $312.1 million.
  • Turnstone Biologics TSBX shares decreased by 11.86% to $2.9. The company's market cap stands at $66.2 million.
  • AbCellera Biologics ABCL shares declined by 10.16% to $3.98. The market value of their outstanding shares is at $1.1 billion. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!